Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 26, 2019 - Issue 1
455
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis

, , , , , , , , , , , , & show all
Pages 10-14 | Received 02 Oct 2018, Accepted 28 Nov 2018, Published online: 24 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

A Di Paolantonio, A Romano, V Guglielmino, F Vitali, MA Sciarrone, G Bisogni, T Verdolotti, M Maceroni, AM Minnella & M Luigetti. (2023) Central nervous system involvement in two siblings affected by hereditary transthyretin amyloidosis 30 years after liver transplantation: a model for gene-silencing therapies. Neurological Research 45:8, pages 773-778.
Read now
João Heitor Marques, João Coelho, Maria João Menéres & João Melo Beirão. (2022) Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives. Clinical Ophthalmology 16, pages 2227-2233.
Read now
João Heitor Marques, João Coelho, Jorge Malheiro, Bernardete Pessoa & João Melo Beirão. (2021) Subclinical retinal angiopathy associated with hereditary transthyretin amyloidosis – assessed with optical coherence tomography angiography. Amyloid 28:1, pages 66-71.
Read now

Articles from other publishers (20)

Chiara Cambieri, Marco Marenco, Tania Colasanti, Carmine Mancone, Alessandro Corsi, Mara Riminucci, Laura Libonati, Federica Moret, Cristina Chimenti, Alessandro Lambiase, Fabrizio Conti, Matteo Garibaldi, Maurizio Inghilleri & Marco Ceccanti. (2023) Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases. Current Neuropharmacology 21:12, pages 2543-2549.
Crossref
David Adams, Yoshiki Sekijima, Isabel Conceição, Marcia Waddington-Cruz, Michael Polydefkis, Andoni Echaniz-Laguna & Mary M Reilly. (2023) Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment. The Lancet Neurology 22:11, pages 1061-1074.
Crossref
Luisa Frizziero, Alessandro Salvalaggio, Eleonora Cosmo, Alberto Cipriani, Edoardo Midena & Chiara Briani. (2023) Ophthalmological involvement in wild‐type transthyretin amyloidosis: A multimodal imaging study. Journal of the Peripheral Nervous System.
Crossref
Junya Kitahara, Shinji Kakihara, Shuji Mukawa, Takao Hirano, Akira Imai, Teruyoshi Miyahara & Toshinori Murata. (2023) Long-term surgical results of trabeculectomy for secondary glaucoma in Val30Met hereditary transthyretin amyloidosis. Scientific Reports 13:1.
Crossref
D. Adams. (2023) Neuropathie amyloïde à transthyrétine : du diagnostic au traitement. Bulletin de l'Académie Nationale de Médecine 207:5, pages 583-593.
Crossref
Efthimios Dardiotis & Theodoros Kyriakides. (2023) Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy. Current Neuropharmacology 21:3, pages 471-481.
Crossref
Nathan Carberry, Sun Yu, Raisy N. Fayerman, Rachelle Dugue, Michael Miller, Kurenai Tanji, Tarini Goyal, Peter Canoll & Thomas H. BrannaganIIIIII. (2022) Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature. The Neurohospitalist 13:1, pages 90-95.
Crossref
Carlos Casasnovas, Laura Lladó, Cristina Borrachero, Patricia Valentina Pérez-Santamaría, Francisco Muñoz-Beamud, Inés Asunción Losada-López, Maria Carme Baliellas-Comellas & Juan González-Moreno. (2023) A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis. Therapeutic Advances in Neurological Disorders 16.
Crossref
Jorge Ruiz-Medrano, Mariluz Puertas, Elena Almazán-Alonso, Marina Fernández-Jiménez, Ignacio Flores-Moreno, Clara Salas Antón, Pablo García-Pavía & José M. Ruiz-Moreno. (2023) OPHTHALMOLOGIC INVOLVEMENT IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS. Retina 43:1, pages 49-56.
Crossref
Thomas H. Brannagan3rd3rd, John L. Berk, Julian D. Gillmore, Mathew S. Maurer, Márcia Waddington‐Cruz, Marianna Fontana, Ahmad Masri, Laura Obici, Michela Brambatti, Brenda F. Baker, Lisa A. Hannan, Gustavo Buchele, Nick J. Viney, Teresa Coelho & Jose Nativi‐Nicolau. (2022) Liver‐directed drugs for t ransthyretin‐mediated amyloidosis . Journal of the Peripheral Nervous System 27:4, pages 228-237.
Crossref
Fukutaro Mano, Yoshihiro Yonekawa, Shinji Kakihara, Jorge Fortun, Enrico Borrelli, Francesco Bandello, Toshinori Murata, Shunji Kusaka, Angela Dispenzieri & Jose S. Pulido. (2022) CHOROIDAL AMYLOID DEPOSITION. Retina 42:10, pages 1989-1994.
Crossref
Shinji Kakihara, Takao Hirano, Junya Kitahara, Yorishige Matsuda, Akira Imai, Teruyoshi Miyahara & Toshinori Murata. (2022) Application of optical coherence tomography angiography to assess systemic severity in patients with hereditary transthyretin amyloidosis. PLOS ONE 17:9, pages e0275180.
Crossref
Pathma Thiagasorupan, Emmanuel Barreau, Gaël Gendron, Eric Frau, Cécile Cauquil, David Adams, Marc Labetoulle & Antoine Rousseau. (2021) Specific postoperative complications of vitrectomy in hereditary transthyretin amyloidosis. European Journal of Ophthalmology 32:2, pages 1149-1156.
Crossref
Shinji Kakihara, Takao Hirano, Junya Kitahara, Yorishige Matsuda, Akira Imai, Teruyoshi Miyahara & Toshinori Murata. (2022) OCULAR ANGIOGRAPHIC FEATURES IN JAPANESE PATIENTS WITH VAL30MET HEREDITARY TRANSTHYRETIN AMYLOIDOSIS. Retina 42:1, pages 210-215.
Crossref
Shinji Kakihara, Takao Hirano, Yorishige Matsuda, Daiki Takano, Akira Imai, Teruyoshi Miyahara & Toshinori Murata. (2021) Deposits on Retinal Surface Seen on OCT in Ocular Amyloidosis. Ophthalmology Retina 5:10, pages 1005-1008.
Crossref
E. Debourdeau, C. Zagroun & V. Daien. (2021) Amylose vitréorétinienne héréditaire : à propos d’un cas. Journal Français d'Ophtalmologie 44:7, pages 1084-1086.
Crossref
Marco Luigetti & Serenella Servidei. (2021) Patisiran in hereditary transthyretin-mediated amyloidosis. The Lancet Neurology 20:1, pages 21-23.
Crossref
Evan T. Powers & Jeffery W. Kelly. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine 65 103 .
M. Grandis, L. Obici, M. Luigetti, C. Briani, F. Benedicenti, G. Bisogni, M. Canepa, F. Cappelli, C. Danesino, G. M. Fabrizi, S. Fenu, G. Ferrandes, C. Gemelli, F. Manganelli, A. Mazzeo, L. Melchiorri, F. Perfetto, L. G. Pradotto, P. Rimessi, G. Tini, S. Tozza, L. Trevisan, D. Pareyson & P. Mandich. (2020) Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet Journal of Rare Diseases 15:1.
Crossref
Shinji Kakihara, Takao Hirano, Akira Imai, Teruyoshi Miyahara & Toshinori Murata. (2020) Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy. Japanese Journal of Ophthalmology 64:5, pages 533-538.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.